Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in JAMA Network Open.
May 30, 2024
0
0
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood sugar.
May 29, 2024
0
1
Diabetes mellitus (DM) is a metabolic disease characterized by pancreatic malfunction and poor production of insulin. Imagine your pancreas is a factory for insulin, a key hormone that keeps your blood sugar level. Inside ...
May 28, 2024
0
9
A recent study by WifOR Institute highlights the societal benefits of early intensified treatment for Type 2 diabetes patients in Korea. Over a 10-year period,12% more patients who started combination therapy during the early ...
May 24, 2024
0
1
Metabolic diseases, such as type 2 diabetes, are associated with compositional shifts in the human gut microbiome, including the fungal fraction called the mycobiome. But research on the mycobiome and how type 2 diabetes ...
May 24, 2024
0
2
A pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and chronic kidney disease. ...
May 24, 2024
0
2
In a paper published in Science Translational Medicine, researchers from City of Hope, a U.S. cancer research and treatment organization and a research center for diabetes and other life-threatening illnesses, report that ...
May 22, 2024
0
16
Men are at greater risk than women of the major health effects of diabetes (types 1 and 2), proposes a long term study published online in the Journal of Epidemiology & Community Health.
May 16, 2024
0
12
An Australian-first study by the Registry of Senior Australians (ROSA) investigating the use of blood sugar-lowering medications among residents with diabetes in aged care homes nationwide, has revealed the rising use of ...
May 16, 2024
0
0
Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular disease (ASCVD) risk, according to a study presented at the annual meeting of the American Association ...
May 16, 2024
0
1
